| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| L795918 | MACKLIN | 拉莫三嗪 | 10mM in DMSO | 467元/1ml; | 咨询 |
|
| L0241 | TCI | Lamotrigine | >98.0%(T)(HPLC) | 150元/1G; 550元/5G; | 咨询 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C9H7Cl2N5 = 256.09 | | 外观与形状(20℃) | 固体 | | 储存温度 | 0-10℃ | | 储存在惰性气体下 | 存放于惰性气体之中 | | 应避免的情况 | 空气,加热 | | Reaxys-RN | 7589268 | | PubChem物质ID | 160871245 | | Merck Index (14) | 5353 | | MDL编号 | MFCD00865333 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Melting point | 216.0 to 220.0 ℃ |
物性(参考值) 安全信息 | 图形或危害标志 |  | | 信号词 | 危险 | | 危险性说明 | H301 : 吞咽会中毒。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P301 + P310 + P330 : 如误吞咽:立即呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | III | | 监管条件代码(*) | |
|
| 185928 | J&K | Lamotrigine | 98%, 一种新型抗惊厥药剂, 可抑制5-羟色胺(5-HT)吸收 | 656元/1G; 2233元/5G; | 咨询 |
基本信息 | 分子式 | C9H7Cl2N5 | | 分子量 | 256.09 | | 熔点 | 216-220 | | MDL编码 | MFCD00865333 | | Beilstein | 7589268 | | Merck | 14,5353 | | EINECS 编号 | 281-901-8 | | 存储条件 | Freezer -20℃ | 产品描述 Lamotrigine是一种新型抗惊厥药剂,作用于人类血小板和大鼠脑突触体,抑制5-羟色胺(5-HT)吸收,IC50分别为240 μM和474 μM。 靶点(IC50 & Targe) 5-HT (human platelets),240μM 5-HT (rat brain synaptosomes),474μM 体外研究 Lamotrigine通过阻断电压依赖性钠通道稳定突触前神经元膜,从而防止兴奋性神经递质,尤其是谷氨酸和天冬氨酸的释放。[1]用10毫克/升藜芦碱培育的大鼠大脑皮层组织,lamotrigine抑制谷氨酸和天冬氨酸(两者ED 50 = 5.38 毫克/升)的释放比抑制GABA (ED50 = 11.2 毫克/升)的释放有效两倍,并且当皮层切片暴露在75毫克/升藜芦碱时,lamotrigine抑制乙酰胆碱的释放(ED50 = 25.6 毫克/升)效力降低很多。基础谷氨酸的释放不受影响。[2] Lamotrigine抑制钠依赖性动作电位的高频率持续节律放电,表明对电压激活的钠离子通道具有直接作用。[3] Lamotrigine不会诱导PCP样中枢神经系统(CNS)效应,不会通过直接抑制NMDA受体发挥作用,并可能导致与NMDA阻断相关的不良效应缺乏。[4] 体内研究 在小鼠和大鼠体内,lamotrigine防止MES和戊四氮诱导的后肢伸展,表明在动物中具有抗癫痫作用。lamotrigine给药后1小时这些作用达到最大值,并且能够持续超过24小时。[4] Lamotrigine在电诱发的EEG后放电测试中是活跃的,这表明其能够抵抗简单和复杂的部分性发作。大鼠体内lamotrigine以>5 毫克/千克的剂量静脉内给药,后放电持续时间剂量依赖性减少。[5] 动物实验 Animal Models: 狗/大鼠 Formulation: 悬浮在0.25%甲基纤维素溶液中 Dosages: 狗和大鼠体内分别为4.5和11.7毫克/千克 Administration: 静脉注射 (Only for Reference) 参考文献 [1] Goa KL, et al. Drugs, 1993, 46(1), 152-176. [2] Leach MJ, et al. Epilepsia, 1986, 27(5), 490-497. [3] Cheung H, et al. Epilepsy Res, 1992, 13(2), 107-112. [4] Miller AA, et al. Epilepsia, 1986, 27(5), 483-489. [5] Wheatley PL, et al. Epilepsia, 1989, 30(1), 34-40. [6] Lamotrigine 安全信息 | 图形或危害标志 |  | | 提示语 | Danger | | 危险说明 | H301 | | 防范说明 | P301+P310 | | UN号码 | 2811 | | 危险分类 | 6.1 | | 包装等级 | III | | WGK | 3 | | RTECS | XY5850700 |
|
| C46085 | Alfa Aesar | Lamotrigine | 98% | 1001元/1g; 3496元/5g; | 咨询 |
基本信息 Ref# 46085 分子式 C9H7Cl2N5 分子量 358.50 GHS危害和防范说明 GHS符号
 Hazard Statements H301 Toxic if swallowed. Precautionary Statements P264 P301+P310 安全信息 危险等级 6.1 |
| PHR1392 | Supelco | Lamotrigine | Pharmaceutical Secondary Standard; Certified Reference Material | 1479.89元/1 G; | 咨询 |
产品说明 一般描述 Lamotrigine is an anticonvulsant drug, which is widely used in the treatment of epilepsy and bipolar disorders. It is also used in combination with other antiepileptics to treat refractory partial seizures, generalized tonic-clonic seizures and generalized toxic-chronic seizures. Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. 应用 These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. Labetalol Hydrochloride may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using spectrophotometric technique. 生化/生理作用 抗惊厥剂。 分析说明 These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAC3640 in the slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C9H7Cl2N5 | | 分子量 | 256.09 | | EC 号 | 281-901-8 | | MDL编号 | MFCD00865333 | | PubChem化学物质编号 | 329823366 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to PhEur Y0001030 traceable to USP 1356756 | | 储存温度 | 2-30℃ | | SMILES string | Nc1nnc(c(N)n1)-c2cccc(Cl)c2Cl | | InChI | 1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16) | | InChI key | PYZRQGJRPPTADH-UHFFFAOYSA-N | | Gene Information | human ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0001030 | | Lamotrigine | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 抗惊厥剂。 包装 Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C9H7Cl2N5 | | 分子量 | 256.09 | | MDL编号 | MFCD00865333 | | PubChem化学物质编号 | 329831227 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | Nc1nnc(c(N)n1)-c2cccc(Cl)c2Cl | | InChI | 1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16) | | InChI key | PYZRQGJRPPTADH-UHFFFAOYSA-N | | Gene Information | human ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0001031 | | Lamotrigine for peak identification | European Pharmacopoeia (EP) Reference Standard | 1861.35元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 抗惊厥剂。 包装 Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C9H7Cl2N5 | | 分子量 | 256.09 | | MDL编号 | MFCD00865333 | | PubChem化学物质编号 | 329831228 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Nc1nnc(c(N)n1)-c2cccc(Cl)c2Cl | | InChI | 1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16) | | InChI key | PYZRQGJRPPTADH-UHFFFAOYSA-N | | Gene Information | human ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0001085 | | Lamotrigine for system suitability | European Pharmacopoeia (EP) Reference Standard | 1259.15元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 抗惊厥剂。 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C9H7Cl2N5 | | 分子量 | 256.09 | | MDL编号 | MFCD00865333 | | PubChem化学物质编号 | 329831255 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | Nc1nnc(c(N)n1)-c2cccc(Cl)c2Cl | | InChI | 1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16) | | InChI key | PYZRQGJRPPTADH-UHFFFAOYSA-N | | Gene Information | human ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| L3791 | Sigma-Aldrich | Lamotrigine | ≥98%, powder | 1956.53元/10 MG; 8084.99元/50 MG; | 咨询 |
产品说明 包装 10, 50 mg in glass bottle 生化/生理作用 抗惊厥剂。 特点和优势 该化合物由 GlaxoSmithKline 开发。想要浏览其他由制药公司开发的化合物以及已批准药物/候选药物清单,请单击此处。 其他说明 斯克里普斯代谢组学和质谱技术中心独立生成的串联质谱数据可在PDFL3791.pdf 中查看或下载。斯克里普斯代谢物组学和质谱技术中心的METLIN代谢物数据库中有测试代谢物。要了解更多信息,请访问sigma.com/metlin。 基本信息 | 经验(实验)分子式 | C9H7Cl2N5 | | 分子量 | 256.09 | | EC 号 | 281-901-8 | | MDL编号 | MFCD00865333 | | PubChem化学物质编号 | 24278792 | | NACRES | NA.77 |
产品性质 | 质量水平 | 200 | | 测定 | ≥98% | | 形式 | powder | | 颜色 | white | | 溶解性 | DMSO: soluble 20 mg/mL at 60 ℃ H2O: insoluble | | 创始人 | GlaxoSmithKline | | 储存温度 | 2-8℃ | | SMILES string | Nc1nnc(c(N)n1)-c2cccc(Cl)c2Cl | | InChI | 1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16) | | InChI key | PYZRQGJRPPTADH-UHFFFAOYSA-N | | Gene Information | human ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) rat ... Scn2a1(24766), Scnn1a(25122) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
|
| 1356756 | USP | Lamotrigine | United States Pharmacopeia (USP) Reference Standard | 12133.8元/150 MG; | 咨询 |
产品说明 生化/生理作用 抗惊厥剂。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C9H7Cl2N5 | | 分子量 | 256.09 | | MDL编号 | MFCD00865333 | | PubChem化学物质编号 | 329750224 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | Nc1nnc(c(N)n1)-c2cccc(Cl)c2Cl | | InChI | 1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16) | | InChI key | PYZRQGJRPPTADH-UHFFFAOYSA-N | | Gene Information | human ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP1097 | | Lamotrigine | British Pharmacopoeia (BP) Reference Standard | 1861.35元/200 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 抗惊厥剂。 包装 Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C9H7Cl2N5 | | 分子量 | 256.09 | | EC 号 | 281-901-8 | | MDL编号 | MFCD00865333 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Nc1nnc(c(N)n1)-c2cccc(Cl)c2Cl | | InChI | 1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16) | | InChI key | PYZRQGJRPPTADH-UHFFFAOYSA-N | | Gene Information | human ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 093440 | Fluorochem | 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine | 95% | 1188元/1g; 4268元/5g; | 咨询 |
基本信息 | CAS Number | 84057-84-1 | | MDL Number | MFCD00865333 | | Boiling Point | 503.1℃ | | Melting Point | 218℃ | | Density | 1.572 |
安全信息 | 图形或危害标志 |   | | 危险性说明 | EUH401: To avoid risks to human health and the environment, comply with the instructions for use. H301: Toxic if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H332: Harmful if inhaled. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing . P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.. P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see relevant procedures. on this label). P330: Rinse mouth. P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to in accordance with local regulation .
|
|